Metformin partially mimicked APN action and activate AMPK signaling in PC-3 cells, with reduction of mTOR activity thus inhibition of cell growth, suggesting that Metformin might have particular value in attenuating the adverse effects of hypoadiponectinemia on PC (34). This evidence concerns the gene ANPEP and adiponectin deficiency.